An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.
Experimental Treatment Gaining Traction Online
The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are encouraged to message these accounts directly for supplier links, while also obtaining promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a flourishing market exists on Telegram, where communities with numerous of participants share comparison images, injection guides and claims of rapid British shipping. Vendors market the drug there before redirecting buyers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Experts Voice Concerns
However, doctors and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals injecting products of uncertain source.
Some professionals stated the demand for the experimental drug could be linked to the increasing cost of approved weight loss products such as Mounjaro.
Regulatory Position and Implementation
Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.
Several influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach medicines, advertising, and consumer regulations, potentially leading to fines, prosecution or prison.
Platform Response and Material Removal
According to the social media company, the platform has taken down violative material and prohibited associated keywords and query recommendations. The organization said it was dedicated to maintaining the service safe and investing in strengthening compliance measures.
Online Marketplace Activities
Research also discovered communities with up to 9,000 participants marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up groups with thousands of members, filled with photos of weight loss, positive testimonials and detailed instructions for mixing or administering at residence.
After moments of entering one community, a seller shared contact information, where most purchases take place. The vendor provided an guidebook and promised shipping within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about weight, health issues or previous experience.
Product Details and Costs
Inside these groups, posts display dark colored packages with postal service stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled pens typically priced at 160 pounds for 20mg. When asked how much time a pen should last, vendors give contradictory answers ranging from a several days to “depends on your body”.
Platform Moderation and Security Actions
A representative for Telegram said it regularly monitored dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting substances they can’t verify. Although the research behind retatrutide is sound, these digital products may not include what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the increase in interest to current price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake injections are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.
Her team has previously seen individuals injured by personal administration from unconfirmed sources. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These materials could be impure or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject users to potentially serious health risks”.
